MEDICA 2023 + COMPAMED 2023 Show the Way Forward in Healthcare
|
By LabMedica International staff writers Posted on 13 Nov 2023 |

An audience of medical professionals from across the world and all areas of the healthcare economy is coming together once again in Düsseldorf, Germany as the internationally leading medical trade fair MEDICA (Düsseldorf, Germany) kicks off on November 13 to 16, 2023, with an unprecedented number of participants including over 5,300 companies from close to 70 countries. COMPAMED, which is held in parallel, is the international leading trade fair for suppliers within the medical technology industry, where about 730 companies from 39 countries are participating. After German companies, the largest bookings of floor space has been from China, Italy, Turkey, South Korea, the USA and other European nations such as France, Spain, the United Kingdom and Poland. At COMPAMED, the USA, Italy and Switzerland are at the top behind Germany.
In the halls of the trade fair grounds, exhibitors are presenting a comprehensive range of medical products, devices and instruments for outpatient and clinical treatment which covers all phases of development, production and marketing. MEDICA determines its focus areas in its five worlds of experience covering the huge range of over 10,000 company innovations related to lab technology and diagnostics, medical technology and electromedicine, commodities and consumables, physiotherapy and orthopedic technology as well as IT systems and IT solutions. The highlights of each MEDICA, in addition to the numerous innovations, traditionally also include multi-faceted accompanying programs with celebrity visits and presentations. Moreover, the keynote speakers are expected to particularly spice up the specialist topics.
The on-stage program of the accompanying conferences and the professional forums integrated into the worlds of experience is offering several other highlights. These include the finals of two start-up competitions on the stage of the MEDICA CONNECTED HEALTHCARE FORUM (Hall 12). At the 12th MEDICA Start-up COMPETITION on Tuesday afternoon (14 November), the focus is on the entire spectrum of innovations for the healthcare sector: from artificial intelligence (AI) to health apps, solutions for laboratory diagnostics and medical robotics. For the first time this year, “sustainability” features as a novel category. The 15th “Healthcare Innovation Worldcup” on Monday afternoon (13 November), by contrast, focuses on intelligent “Internet of Medical Things” (IoMT) solutions such as digital biomarkers, smart bandages and network-connectible wearables.
A key trend currently shaping the market is the growing trend of “outpatientisation”. This puts the focus on “point-of-care” products and services that includes patient-oriented diagnostics and treatment, as well as telemedical applications for optimal, cross-sector networking among all those involved in the care process. Other current key trends are procedures based on artificial intelligence (AI) and supporting systems, such as robotic systems or VR/AR (virtual reality/augmented reality) applications, as well as solutions for the implementation of more sustainable processes along the supply and added value chain.
At COMPAMED 2023 in the trade fair Halls 8a and 8b, medical technology industry suppliers are showing what they are capable of. The exhibiting companies are also presenting (five) worlds of experience including a wide range of high-tech and service solutions. The five worlds of experience are: Manufacturing & Devices (e.g., components, parts, manufacturing processes), Services & Advice (e.g., research, development, services), Materials (e.g., plastics, glass, ceramics, metals, composite materials, adhesives, packaging), Micro Tech (such as micro components, microfluidics) as well as IT in Tech (software development and maintenance for medical technology). The program sessions, the COMPAMED HIGH-TECH FORUM and the COMPAMED SUPPLIERS FORUM will be following important industry and technological trends and provide practical information related to new procedures, products and relevant aspects of work on international markets.
Related Links:
MEDICA
Latest Medica 2023 News
- Absology Showcases Latest Advancements in Medical Diagnostics
- Noul Showcases AI-Driven Blood and Cancer Diagnostic Platform
- Oruba Presents State-of-the-Art Self-Operating Uroflowmeters
- Awareness Technology Exhibits Incredibly Flexible ChemWell 2 ELISA and Chemiluminescent Analyzer
- BioVendor Group Demonstrates Unique IVD Platform and Immunoblot Test
- Greiner Bio-One Highlights Magnetic 3D Cell Culture Technology
- Fujirebio Showcases Range of Novel Testing Solutions
- Sentinel Diagnostics Demonstrates New SENTiNAT 200 and STAT-NAT Kits for Infectious Diseases
- DiaSys Showcases High Quality Diagnostic Reagents and System Solutions
- Randox Exhibits Full Range of Molecular Diagnostic Solutions
- Alcor Scientific Demonstrates Fully-Automated ESR Analyzers
- Bosch Healthcare Presents Vivalytic Point-of-Care PCR System
- CerTest Presents Innovations Related to VIASURE Products
- Vircell Highlights All-in-One CLIA System and Real Time PCR Kits
- Tianlong Showcases Cutting-Edge Products and Innovative Molecular Diagnostic Solutions
- Getein Biotech Exhibits Advanced POCT Analyzers
Channels
Clinical Chemistry
view channel
Long-Term Data Show PSA Screening Modestly Reduces Prostate Cancer Deaths
Prostate cancer is among the most common cancers in men, and the role of population screening has remained controversial because of overdiagnosis and overtreatment. Health systems have sought clearer,... Read more
Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively
Lung cancer remains difficult to monitor for early progression and treatment resistance, while pulmonary fibrosis continues to pose major challenges for early diagnosis. Clinicians need repeatable, noninvasive... Read moreMolecular Diagnostics
view channel
New Computational Tool Reveals Genetic Driver of Idiopathic Neuropathy
Peripheral neuropathy is a common neurological disorder that causes pain, sensory loss, imbalance, and weakness, affecting an estimated 12%–20% of people in the U.S. and nearly 30% of adults over age 65.... Read more
Breast Cancer-Specific Signatures Link Genome Instability to Outcomes
Genomic instability is a hallmark of cancer, but most genomic analyses have relied on broad signatures shared across multiple malignancies, limiting their precision for individual tumor types.... Read moreHematology
view channel
Stem Cell Biomarkers May Guide Precision Treatment in Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is an aggressive blood cancer that most often affects older adults and still carries a poor prognosis despite therapeutic advances. Venetoclax-based regimens have improved... Read more
Advanced CBC-Derived Indices Integrated into Hematology Platforms
Diatron, a STRATEC brand, has introduced six advanced hematological indices on its Aquila, Aquarius 3, and Abacus 5 hematology analyzers. The new Research Use Only (RUO) indices include Neutrophil-to-Lymphocyte... Read moreImmunology
view channel
Routine TB Screening Test May Reveal Immune Aging and Mortality Risk
Immune aging is associated with weaker responses to vaccination, greater risks of infection, and higher levels of inflammation. Leveraging routinely ordered laboratory tests to quantify that responsiveness... Read more
Biomarkers and Molecular Testing Advance Precision Allergy Care
Allergic diseases often present with similar symptoms but can be driven by distinct biological mechanisms, making standardized care inefficient for many patients. Historically, individuals with pollen... Read moreMicrobiology
view channel
Study Finds Hidden Mpox Infections May Drive Ongoing Spread
Mpox continues to circulate despite vaccination, and many cases show no known link to a symptomatic partner. The role of people without symptoms has remained uncertain, limiting clarity on how transmission persists.... Read more
Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals
Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Molecular Urine and Stool Tests Do Not Improve Early TB Treatment in Hospitalized HIV Patients
Tuberculosis is the leading cause of death among people living with HIV, and diagnosis in hospital settings remains difficult. Symptoms are often non-specific, disease can be extrapulmonary, and many patients... Read morePathology
view channel
Rapid AI Tool Predicts Cancer Spatial Gene Expression from Pathology Images
Gene expression profiling can inform tumor biology and treatment selection, but spatial assays remain costly and time-consuming. Results can take weeks and cost thousands of dollars, limiting large-scale... Read more
AI Pathology Test Receives FDA Breakthrough for Bladder Cancer Risk Stratification
Non–muscle invasive bladder cancer has highly variable outcomes, complicating surveillance and treatment planning. Risk assessment typically relies on stage, grade, and tumor size, leaving uncertainty... Read moreTechnology
view channel
AI Tool Automates Validation of Laboratory Software Configuration Changes
Regulated laboratories face heavy documentation and requalification demands when software configurations change, slowing improvements and discouraging beneficial updates. A new capability now automates... Read more
Point-of-Care Testing Enhances Health Literacy and Self-Management in Chronic Disease
Limited access to general practitioners and pathology services can delay diagnosis and monitoring for people in regional and remote communities. Rapid, on-the-spot testing can shorten turnaround times... Read moreIndustry
view channel
AI-Powered Multi-Functional Analyzer Wins German Innovation Award
Hematology services are increasingly delivered across distributed care settings, where limited staffing and complex workflows can extend turnaround times. Advanced morphology review still often depends... Read more









